Terms: = Liver cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
800 results:
1. SUV max as Predictor of Metastatic Disease on 18 F-FDG PET-CT in Hepatocellular Carcinoma.
Ashfaq W; Rehman K; Shahid A; Younis MN
J Coll Physicians Surg Pak; 2024 Apr; 34(4):394-399. PubMed ID: 38576279
[TBL] [Abstract] [Full Text] [Related]
2. Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast cancer with [
Altena R; Burén SA; Blomgren A; Karlsson E; Tzortzakakis A; Brun N; Moein MM; Jussing E; Frejd FY; Bergh J; Tran TA; Hartman J; Axelsson R
J Nucl Med; 2024 May; 65(5):700-707. PubMed ID: 38548353
[TBL] [Abstract] [Full Text] [Related]
3. Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.
Liu Y; Guerrero DQ; Lechuga-Ballesteros D; Tan M; Ahmad F; Aleiwi B; Ellsworth EL; Chen B; Chua MS; So S
Int J Nanomedicine; 2024; 19():2639-2653. PubMed ID: 38500681
[TBL] [Abstract] [Full Text] [Related]
4.
Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
6. [
Rosar F; Burgard C; Larsen E; Khreish F; Marlowe RJ; Schaefer-Schuler A; Maus S; Petto S; Bartholomä M; Ezziddin S
Cancer Imaging; 2024 Feb; 24(1):27. PubMed ID: 38389092
[TBL] [Abstract] [Full Text] [Related]
7. A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [
Trautwein NF; Schwenck J; Seitz C; Seith F; Calderón E; von Beschwitz S; Singer S; Reischl G; Handgretinger R; Schäfer J; Lang P; Pichler BJ; Schulte JH; la Fougère C; Dittmann H
Theranostics; 2024; 14(3):1212-1223. PubMed ID: 38323317
[No Abstract] [Full Text] [Related]
8. Co-Reactive Ligand In Situ Engineered Gold Nanoclusters with Ultra-Bright Near-Infrared Electrochemiluminescence for Ultrasensitive and Label-Free Detection of Carboxylesterase Activity.
Guo W; Xia M; Peng D; Zhao Y; Nie Y; Zhou Y
Anal Chem; 2024 Feb; 96(6):2369-2377. PubMed ID: 38310525
[TBL] [Abstract] [Full Text] [Related]
9. [
Vimalnath KV; Rajeswari A; Dixit A; Chakravarty R; Sarma HD; Kulkarni S; Jha A; Puranik A; Rangarajan V; Goswami M; Chakraborty S
Cancer Biother Radiopharm; 2024 Feb; 39(1):82-91. PubMed ID: 38265675
[No Abstract] [Full Text] [Related]
10. Potential Added Value of
Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
[TBL] [Abstract] [Full Text] [Related]
11. The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Yang Y; Li L; Xu Y; Ouyang J; Zhou Y; Ye F; Huang Z; Zhang W; Zhou A; Zhao X; Cai J; Wang Y; Zhou J; Zhao H
Radiol Med; 2024 Feb; 129(2):188-201. PubMed ID: 38180570
[TBL] [Abstract] [Full Text] [Related]
12.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
13. Patlak Reconstruction Using Dynamic 18 F-FDG PET Imaging for Evaluation of Malignant liver Tumors : A Comparison of HCC, ICC, and Metastatic liver Tumors.
Kaneko K; Nagao M; Yamamoto A; Yano K; Honda G; Tokushige K; Sakai S
Clin Nucl Med; 2024 Feb; 49(2):116-123. PubMed ID: 38108830
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [
Krokos G; Kotwal T; Malaih A; Barrington S; Jackson P; Hicks RJ; Marsden PK; Fischer BM
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38100790
[TBL] [Abstract] [Full Text] [Related]
15. Technical Note: Impact of impurities on Yttrium-90 glass microsphere activity quantitation.
Beattie BJ; Kirov AS; Kesner AL
Med Phys; 2024 Mar; 51(3):2306-2310. PubMed ID: 37956259
[TBL] [Abstract] [Full Text] [Related]
16. A prospective study of
Shamim SA; Kumar N; Arora G; Jaswal S; Shalimar ; Gamanagatti S; Bal C
Ann Nucl Med; 2024 Feb; 38(2):103-111. PubMed ID: 37926772
[TBL] [Abstract] [Full Text] [Related]
17. Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic Study.
AbdelMagid AM; Abbassi MM; Ebeid FS; Farid SF; El-Sayed MH
Clin Ther; 2024 Jan; 46(1):e12-e22. PubMed ID: 37925363
[TBL] [Abstract] [Full Text] [Related]
18. Head-to-head comparison of
Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
[TBL] [Abstract] [Full Text] [Related]
19. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
Mudavath S; Ashok D
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
[TBL] [Abstract] [Full Text] [Related]
20. Explosomes: A new modality for DEB-TACE local delivery of sorafenib: In vivo proof of sustained release.
Sakr OS; Zaitoun MMA; Amer MS; Qubisi M; Elshafeey AH; Jordan O; Borchard G
J Control Release; 2023 Dec; 364():12-22. PubMed ID: 37816482
[TBL] [Abstract] [Full Text] [Related]
[Next]